NEW YORK – Japanese diagnostics device firm Sysmex and artificial intelligence company Optim said on Friday that they have agreed to establish a joint venture aimed at the development and operation of services and platforms for digital medicine.
The two companies formed a business alliance this February and have been collaborating on initiatives to combine Sysmex’s global sales and service network with Optim’s artificial intelligence and data management technologies, including a product it calls Optim Cloud IoT OS.
Under the newly agreed upon joint venture, the partners said that they plan to develop and test new diagnostic methods that combine image information from gene tests with AI analysis, as well as to use AI for image processing of various data obtained from existing Sysmex analyzers.
The venture, which they plan to establish in January, will also seek collaborations with pharmaceutical companies, manufacturers of medical devices, and other companies, the firms said. Some discussions are already ongoing with potential pharma and device partners.
Financial terms of the agreement were not disclosed.